Seagen Inc. , a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally.
Seagen stock last closed at $136.00, down 1.45% from the previous day, and has decreased 3.4% in one year. It has overperformed other stocks in the Biotechnology industry by 0.12 percentage points. Seagen stock is currently +29% from its 52-week low of $105.43, and -25.68% from its 52-week high of $183.00.
At the moment, there are 185.66M shares of SGEN outstanding. The market value of SGEN is $25.25B. In the last 24 hours, 567,125 SGEN shares were traded.
You need a brokerage account to access the NASDAQ market and buy SGEN shares.
Based on our experience, eToro is the best stock brokerage. Here's why:
Get $10 towards your purchase of stock by opening an account with eToro now.
Open eToro AccountNow that you've selected your brokerage, it's time to fill out some personal information so you can buy SGEN stock today.
Now that you have finished signing up on apps for stocks, you need to deposit funds:
Watch the tutorial below to see the process of depositing money into your investment account.
Once you have figured out the best place to buy Seagen stock, it's absolutely critical to analyze their stock prior to buying, so you actually understand the risk as well as the upside.
WallStreetZen was created to help everyday investors perform more accurate fundamental analysis.
You can view all of the due diligence checks on SGEN's stock page.
Investors use many financial metrics, analyses, models, and charts to gauge SGEN's true value.
Using relative valuations measures:
You can access additional valuation research on SGEN's stock here.
Out of 13 sell side analysts who give ratings on SGEN, the consensus analyst rating on Seagen is a Buy
Please keep in mind that analyst forecasts are not stock recommendations, nor are they investment advice.
Reni Benjamin, a bottom 8% analyst from JMP Securities reiterates SGEN with a buy rating and maintains their SGEN price target from $142.00 to $142.00, on Feb 6, 2023.
Andrew Berens, a bottom 2% analyst from SVB Leerink downgrades SGEN to a hold rating and lowers their SGEN price target from $162.00 to $141.00, on Feb 6, 2023.
Shanshan Xu, a bottom 42% analyst from Berenberg maintains SGEN with a strong buy rating and lowers their SGEN price target from $183.00 to $170.00, on Jan 25, 2023.
Matthew Harrison, a bottom 6% analyst from Morgan Stanley maintains SGEN with a strong buy rating and lowers their SGEN price target from $171.00 to $170.00, on Jan 24, 2023.
Asthika Goonewardene, a bottom 11% analyst from Truist Securities initiates coverage on SGEN with a hold rating and announces their SGEN price target of $135.00, on Nov 21, 2022.
You can dig deeper into what analysts are projecting on the Seagen stock forecast page.
Last year, SGEN revenue was $1.86B. In the past 5 year, SGEN's revenue has gone up by 32.41% per year. This was slower than the Biotechnology industry average of 75.62%.
You can analyze SGEN's earnings and revenue performance here.
In the last year, insiders at SGEN have bought more shares than they have sold.
Roger D. Dansey, President RD CMO of SGEN, was the latest SGEN insider to sell. They sold $108,461.16 worth of SGEN stock on Feb 2, 2023.
Research more about who owns SGEN shares here.
No, Seagen doesn't provide an income stream by paying out dividends.
One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other community members have to say.
You have two main types of orders:
Click the Open button and your broker will place the order.
If you need additional help with buying stocks on eToro, watch the how to video below:
Now that you own some SGEN stock, you'll want to keep up with your investment.
Make a watchlist to get the latest updates about your SGEN stock.
To summarize, here are the 6 steps to buy Seagen stock:
If you are looking for a online brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you want to keep tabs on your investment in Seagen, create a watchlist today.